Dow Up 0.64% Nasdaq Up 0.68%

Celgene Corporation (CELG)

-NasdaqGS
93.27 Up 1.01(1.09%) Sep 18, 4:00PM EDT
|After Hours : 93.49 Up 0.22 (0.24%) Sep 18, 7:57PM EDT
Prev Close:92.26
Open:92.98
Bid:92.78 x 100
Ask:93.90 x 100
1y Target Est:102.69
Beta:1.1
Next Earnings Date:23-Oct-14CELG Earnings announcement
Day's Range:92.17 - 93.33
52wk Range:66.85 - 96.44
Volume:2,720,478
Avg Vol (3m):4,485,410
Market Cap:74.57B
P/E (ttm):29.68
EPS (ttm):3.14
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CELGUp 1.09%74.57B
JNJUp 1.09%302.76B

Key Statistics

Forward P/E (1 yr):19.07
P/S (ttm):10.49
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :3.68
Quarterly EPS Est (Sep-14) :0.95
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):0.96

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback